Literature DB >> 24763839

Age- and gender-related differences in drug utilisation and adverse drug reaction patterns among patients in a coronary care unit.

Nitin Subhashchandra Kunnoor1, Padmini Devi, Deepak Yogesh Kamath, Naveen Anthony, Jesso George.   

Abstract

INTRODUCTION: This study aimed to examine age- and gender-related differences in the comorbidities, drug utilisation and adverse drug reaction (ADR) patterns of patients admitted to a coronary care unit (CCU).
METHODS: The present study was a retrospective cohort study. Two trained physicians independently reviewed the case records of CCU patients over a period of one year (Jan-Dec 2008). The demographic, clinical, and drug prescription data of the patients were analysed according to age group (18-59 years vs ≥ 60 years) and gender.
RESULTS: A total of 574 patients were admitted to the CCU during the study period. Of these 574 patients, 65.2% were male, and 48.4% were ≥ 60 years old. No significant gender-based differences were found for the prescription of cardiovascular and non-cardiovascular drugs, and ADR patterns (p > 0.05). Male patients aged ≥ 60 years were found to have a higher rate of polypharmacy than those aged 18-59 years (p = 0.001). The duration of hospital stay was longer in male than female patients (p = 0.008), and the duration of CCU stay was longer for male patients aged ≥ 60 years than males aged 18-59 years (p = 0.013). Compared to patients aged 18-59 years, a greater number of patients aged ≥ 60 years were prescribed cardiovascular (p = 0.006) and non-cardiovascular drugs (p = 0.015). Patients aged ≥ 60 years also had a higher rate of polypharmacy (p = 0.001) and ADRs (p = 0.013), and a longer duration of CCU stay (p = 0.013). Renal (p = 0.047) and cutaneous (p = 0.003) ADRs were found to be more common in patients aged ≥ 60 years.
CONCLUSION: No major gender-related differences were observed in the prescription, drug utilisation and ADR patterns of our study cohort. Higher drug utilisation, ADR rates, and longer duration of CCU stay were noted in patients aged ≥ 60 years.

Entities:  

Mesh:

Year:  2014        PMID: 24763839      PMCID: PMC4291951          DOI: 10.11622/smedj.2014056

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  33 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Patterns, predictors and preventability of adverse drug reactions in the coronary care unit of a tertiary care hospital.

Authors:  Padmini Devi; Deepak Y Kamath; Naveen Anthony; Sushma Santosh; Brendan Dias
Journal:  Eur J Clin Pharmacol       Date:  2011-10-19       Impact factor: 2.953

3.  Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative.

Authors:  Andra L Blomkalns; Anita Y Chen; Judith S Hochman; Eric D Peterson; Kelly Trynosky; Deborah B Diercks; Gerard X Brogan; William E Boden; Matthew T Roe; E Magnus Ohman; W Brian Gibler; L Kristin Newby
Journal:  J Am Coll Cardiol       Date:  2005-03-15       Impact factor: 24.094

4.  Suboptimal management of cardiovascular risk factors in coronary heart disease patients in primary care occurs particularly in women.

Authors:  A Driscoll; A Beauchamp; G Lyubomirsky; L Demos; J McNeil; A Tonkin
Journal:  Intern Med J       Date:  2010-06-01       Impact factor: 2.048

5.  Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland.

Authors:  P Jousilahti; E Vartiainen; J Tuomilehto; P Puska
Journal:  Circulation       Date:  1999-03-09       Impact factor: 29.690

Review 6.  Women and ischemic heart disease: evolving knowledge.

Authors:  Leslee J Shaw; Raffaelle Bugiardini; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2009-10-20       Impact factor: 24.094

7.  Use of evidence-based pharmacotherapy after myocardial infarction in Estonia.

Authors:  Toomas Marandi; Aleksei Baburin; Tiia Ainla
Journal:  BMC Public Health       Date:  2010-06-23       Impact factor: 3.295

8.  Sex-related variations in the frequency and characteristics of adverse drug reactions.

Authors:  C Domecq; C A Naranjo; I Ruiz; U Busto
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1980

9.  Sex-specific trends in midlife coronary heart disease risk and prevalence.

Authors:  Amytis Towfighi; Ling Zheng; Bruce Ovbiagele
Journal:  Arch Intern Med       Date:  2009-10-26

10.  Gender differences in health care use among the elderly population in areas of Norway and Finland. A cross-sectional analysis based on the HUNT study and the FINRISK Senior Survey.

Authors:  Anna Liisa Suominen-Taipale; Tuija Martelin; Seppo Koskinen; Jostein Holmen; Roar Johnsen
Journal:  BMC Health Serv Res       Date:  2006-09-04       Impact factor: 2.655

View more
  3 in total

1.  Adverse drug reaction profile in Amravati region of India: A pharmacovigilance study.

Authors:  Kishor A Bansod; Mohammed Shakeel Mohammed Bashir; Shilpa S Ingle
Journal:  J Pharm Bioallied Sci       Date:  2020-04-10

2.  Multifaceted interventions for improving spontaneous reporting of adverse drug reactions in a general hospital in China.

Authors:  Huan Fang; Xiaowen Lin; Jun Zhang; Zhen Hong; Kenji Sugiyama; Takao Nozaki; Tetsuro Sameshima; Susumu Kobayashi; Hiroki Namba; Tetsuya Asakawa
Journal:  BMC Pharmacol Toxicol       Date:  2017-06-26       Impact factor: 2.483

Review 3.  Age-Related Variation in the Provision of Primary Care Services and Medication Prescriptions for Patients with Cardiovascular Disease.

Authors:  Qiang Tu; Karice Hyun; Nashid Hafiz; Andrew Knight; Charlotte Hespe; Clara K Chow; Tom Briffa; Robyn Gallagher; Christopher M Reid; David L Hare; Nicholas Zwar; Mark Woodward; Stephen Jan; Emily R Atkins; Tracey-Lea Laba; Elizabeth Halcomb; Tim Usherwood; Laurent Billot; Julie Redfern
Journal:  Int J Environ Res Public Health       Date:  2022-08-29       Impact factor: 4.614

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.